AMPICILLIN SODIUM Recall D-0591-2023
Description: Ampicillin and Sulbactam for Injection, USP 3 gram per vial, Rx only, Manufactured for: Civica Inc. Lehi Utah 84043, NDC 72572-022-10
AMPICILLIN SODIUM Recall D-0591-2023 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0591-2023 |
Event ID | 92341 |
Brand | AMPICILLIN AND SULBACTAM |
Generic Name | AMPICILLIN AND SULBACTAM |
Manufacturer | AMPICILLIN AND SULBACTAM |
Original Package? | 1 |
Active Substance | AMPICILLIN SODIUM SULBACTAM SODIUM |
Drug Route | INTRAMUSCULAR |
Distribution | Nationwide within the United States |
Quantity | 419,680 vials |
Recall Reason | Lack of Assurance of Sterility |
Drug Classification | Class II |
Drug Code Info | 20230524 |
Product NDC | 72572-021 72572-022 |
Recall Initiation Date | 20230515 |
Report Date | 20230524 |
Classification Date | 20230518 |
Address | 911 G I D C Makarpura Vadodara, India |
Recalling Firm | Astral SteriTech Private Ltd. |
Initial Notification | Letter |
Unique Ingredient Identifier | JFN36L5S8K DKQ4T82YE6 |
Drug Application Number | ANDA090579 |
Structured Product Labeling (SPL ID) | 29b2046c-a9eb-4dac-8322-20ff4a6c1f73 |
Structured Product Labeling (SPL Set ID) | 1826e630-5305-4d76-91d6-009ed1caef4d |
Similar To |